RSV in transplant and immunocompromised patients.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39231600.
- Also identified by DOI 10.3949/ccjm.91.s1.06.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.
Medical subject headings
- Immunocompromised Host
- Respiratory Syncytial Virus Infections